The FDA is getting the word out on a high-risk issue related to artery-clearing catheters from BD’s Bard Peripheral Vascular ...
BD recently issued a medical device correction later related to its Bard subsidiary's Rotarex atherectomy system.
A medical supply company has agreed to pay $17 million in Georgia to resolve allegations that they violated various laws by providing free samples and discounts to doctors to use their prescription ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback